🇺🇸 FDA
Patent

US 8080523

Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels

granted A61KA61K38/1767A61K47/542

Quick answer

US patent 8080523 (Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels) held by The Regents of the University of California expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K38/1767, A61K47/542, A61K47/6415, A61P